4//SEC Filing
Campbell Robert 4
Accession 0001127602-10-002332
CIK 0001145197other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:34 PM ET
Size
11.2 KB
Accession
0001127602-10-002332
Insider Transaction Report
Form 4
INSULET CORPPODD
Campbell Robert
Vice President for Clinical
Transactions
- Exercise/Conversion
Common Stock
2010-01-25$11.64/sh+1,140$13,270→ 63,633 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-01-25−277→ 82 totalExercise: $5.94Exp: 2016-03-13→ Common Stock (277 underlying) - Exercise/Conversion
Common Stock
2010-01-25$5.94/sh+277$1,645→ 62,493 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-01-25−1,140→ 382 totalExercise: $11.64Exp: 2017-01-24→ Common Stock (1,140 underlying)
Footnotes (3)
- [F1]This option may be exercised at any time, whether vested or not, but, upon termination of employment, we may repurchase any unvested shares at the exercise price paid for the shares. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal monthly installments each month thereafter for 36 months, subject to continued employment.
- [F2]This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal monthly installments each month thereafter for 36 months, subject to continued employment.
- [F3]Includes 992 shares acquired under the 2007 Insulet Corporation Employee Stock Purchase Plan on June 30, 2009.
Documents
Issuer
INSULET CORP
CIK 0001145197
Entity typeother
Related Parties
1- filerCIK 0001404060
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:34 PM ET
- Size
- 11.2 KB